Transaction overview
01Hoth Therapeutics, Inc. completed a $2.0M registered direct at $0.70 per share. H.C. Wainwright & Co. acted as exclusive placement agent for the financing.
- Financing type
- Registered Direct
- Announcement date
- Apr 1, 2026
- Pricing date
- —
- Closing date
- Apr 2, 2026
- Filing date
- Apr 2, 2026
- Status
- Closed
- Market cap before announcement
- $13.3M
- Prior closing price
- $0.8403
- Raise as % of market cap
- 15.1%
Market data · FMP
- Historical market cap
- $13,270,300
- Market date
- Mar 31, 2026
- Closing price
- $0.8403
- Latest reported shares outstanding
- 13,259,027
- Latest reported float shares
- 12,705,463
- Share-data date
- Sep 5, 2026
Market cap and closing price are from FMP for the date shown. Shares are FMP’s latest available snapshot, dated separately. Updated Sep 30, 2026.
Financial Modeling Prep ↗Financing terms
02Equity
- Common shares issued
- 2,857,144
- Price per share
- $0.70
- Pre-funded warrants
- —
- Pre-financing shares disclosed in filing
- 16,270,499
- Shares outstanding after financing
- —
Investor warrants
- Warrant shares
- 2,857,144
- Cash exercise price
- $0.85
- Term
- Five and one-half years from issuance; exercisable six months after issuance.
- Initial exercisability
- —
- Beneficial ownership limits
- 4.99%; may increase to 9.99% with at least 61 days’ prior notice.
View disclosed legal provisions
Cashless exercise: Such Warrants may be exercised on a cashless basis if at the time of exercise there is no effective registration statement registering, or the prospectus contained therein is not available for the resale of, the shares issuable upon exercise of Warrants.
Anti-dilution: The exercise price is subject to customary adjustments in the event of stock splits, stock dividends and similar recapitalization transactions.
Placement agent warrants
- Warrant shares
- 142,857
- Cash exercise price
- $0.875
- Term
- Five years from commencement of sales; immediately exercisable upon issuance.
- Initial exercisability
- —
- Beneficial ownership limits
- —
Compensation warrants are excluded from investor warrant coverage.
View disclosed legal provisions
Cashless exercise: —
Anti-dilution: —
Fees & transaction economics
03- Placement agent / underwriting fee
- 7%
- Agent fee amount
- $140,000.06
- Management fee
- 1%
- Other offering expenses (estimated)
- —
- Net proceeds (estimated)
- —
- Net proceeds as % of gross
- —
Fee amounts reflect disclosed inputs. Unknown expense components are not assumed to be zero.
In addition, the Company agreed to pay the Placement Agent $20,000 for non-accountable expenses and $35,000 for fees and expenses of legal counsel and other out-of-pocket expenses and $15,950 for clearing fees.
Transaction participants
04Source documents
05SEC filings, exhibits and attributed market data. The report separates disclosed facts, calculated metrics, and unknown terms.
Filing evidence & original calculations
16270499
As of March 31, 2026, the aggregate market value of our outstanding common stock held by non-affiliates was approximately $17,917,269 based on 16,270,499 outstanding shares of common stockOriginal source ↗
0.84
On March 31, 2026, the last sale price of our common stock as reported on The Nasdaq Capital Market was $0.84 per shareOriginal source ↗
2857144
unregistered warrants to purchase up to an aggregate of 2,857,144 shares of common stockOriginal source ↗
5.5
will expire five and one-half years following the date of issuanceOriginal source ↗
Five and one-half years from issuance; exercisable six months after issuance.
The unregistered warrants will become exercisable six months following the date of issuance and will expire five and one-half years following the date of issuance.Original source ↗
Such Warrants may be exercised on a cashless basis if at the time of exercise there is no effective registration statement registering, or the prospectus contained therein is not available for the resale of, the shares issuable upon exercise of Warrants.
Such Warrants may be exercised on a cashless basis if at the time of exercise there is no effective registration statement registering, or the prospectus contained therein is not available for the resale of, the shares issuable upon exercise of Warrants.Original source ↗
The exercise price is subject to customary adjustments in the event of stock splits, stock dividends and similar recapitalization transactions.
The exercise price is subject to customary adjustments in the event of stock splits, stock dividends and similar recapitalization transactions.Original source ↗
4.99%; may increase to 9.99% with at least 61 days’ prior notice.
The Warrant contains a beneficial ownership limitation which provides that the Company shall not effect any exercise, and a holder shall not have the right to exercise, any portion of an Warrant to the extent that, after giving effect to the exercise, such holder (together with such holder’s affiliates) would beneficially own in excess of 4.99% of the number of shares of common stock outstanding immediately after giving effect to the issuance of shares issuable upon the exercise. This limitation may be waived (up to a maximum of 9.99%) by a holder in its sole discretion upon not less than sixty-one (61) days’ prior notice to the Company.Original source ↗
0.875
exercise price equal to 125.0% of the Offering price per share of Common Stock, or $0.875 per shareOriginal source ↗
5
exercisable immediately upon issuance for a period of five years following the commencement of the sales pursuant to the OfferingOriginal source ↗
Five years from commencement of sales; immediately exercisable upon issuance.
exercisable immediately upon issuance for a period of five years following the commencement of the sales pursuant to the OfferingOriginal source ↗
1
management fee equal to 1.0% of the gross proceeds raised in the OfferingOriginal source ↗
In addition, the Company agreed to pay the Placement Agent $20,000 for non-accountable expenses and $35,000 for fees and expenses of legal counsel and other out-of-pocket expenses and $15,950 for clearing fees.
In addition, the Company agreed to pay the Placement Agent $20,000 for non-accountable expenses and $35,000 for fees and expenses of legal counsel and other out-of-pocket expenses and $15,950 for clearing fees.Original source ↗
Original SEC calculation; as of 2026-03-31.
As of March 31, 2026, the aggregate market value of our outstanding common stock held by non-affiliates was approximately $17,917,269 based on 16,270,499 outstanding shares of common stock, of whichOriginal source ↗
Original SEC calculation; as of 2026-03-31.
On March 31, 2026, the last sale price of our common stock as reported on The Nasdaq Capital Market was $0.84 per shareOriginal source ↗